Nanostructured Materials for Biomedical Applications: Opportunities and Challenges

Dear Colleagues,

In recent years, research on nanostructured materials has offered materials with unique properties that can be used in various biomedical applications and improve human healthcare. Multiple classes of nanomaterials including inorganic and polymeric nanoparticles, liposomes, nanocrystals, nanotubes, dendrimers and nanopatterned materials, both 2D and 3D, as well as nanocomposites can be specifically designed and functionalized to be biocompatible and have clinical value. Nanostructured material applications in tissue engineering, tissue repair and remodeling, cell engineering, drug delivery, hyperthermia, and imaging agents for both the diagnosis and treatment of several conditions offer potential advantages in clinics. These materials further enable the creation of innovative therapeutic platforms and optimize conventional treatments to address challenges to the delivery of drugs to the affected organ/tissue, enabling the development of more specific and controlled therapeutics. Nanostructured materials also allow the development of disease treatments based on the implementation of nanotechnological tools in disease diagnosis and therapy.

Nonetheless, while nanostructured materials may present many potential advantages and provide several opportunities for biomedical and diagnostic applications, their interaction with biological systems poses numerous challenges as well as opportunities. This Special Issue aims to explore the role and applications of nanostructured materials for biological and biomedical applications to treat different cellular structures, organs, and biological systems. Ultimately, we hope that this Special Issue will effectively present the emerging aspects of nanostructured biomaterials and their advancements in cancer, tissue engineering, disease diagnosis, drug delivery and therapeutic outlooks.

Dr. Karthikeyan Narayanan
Dr. Ramar Thangam
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanostructured materials
• biomaterials
• biomedical materials
• material implants
• stimuli-responsive biomaterials
• tissue regeneration
• tissue repair
• cancer therapy
• drug delivery
• theragnostics